Commentary by a clinical scientist in psychopharmacological research.
暂无分享,去创建一个
[1] D. Klein,et al. The Flawed Basis for FDA Post-Marketing Safety Decisions: The Example of Anti-Depressants and Children , 2006, Neuropsychopharmacology.
[2] D. Klein,et al. PSYCHIATRIC REACTION PATTERNS TO IMIPRAMINE , 1962 .
[3] L. Hollister,et al. Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital. , 1960, The American journal of psychiatry.
[4] D. Klein,et al. Mepazine (pacatal): Clinical trial with placebo control and psychological study , 1960, Psychopharmacologia.
[5] D F Klein,et al. Importance of psychiatric diagnosis in prediction of clinical drug effects. , 1967, Archives of general psychiatry.